Post TAVR Cognitive Function at Short Term: Better or Worse?

Post TAVR Cognitive Function at Short TermThere is little information on the short and mid-term evolution of cognitive function after transcatheter aortic valve replacement (TAVR).

 

The aim of this study was to describe global changes in cognitive function and changes in specific cognitive domains one year after TAVR.

 

Fifty one patients undergoing TAVR, median age 80, were prospectively followed to assess cognitive function using the Montreal Cognitive Assessment Test (MoCA) at baseline, 30 days and one year. Specific cognitive functions (e.g. verbal fluency) were assessed with pertinent tests.

 

Baseline MoCA outcomes, which assesses cognition globally, was 22.71 ± 3.84. Twenty patients (39.2%) showed cognitive decline at baseline, according to test results (<23 of 30 points).

 

MoCA scores improved at short term after TAVR and remained stable at one year (p = 0.022). There were no significant changes over time in specific cognitive domain test outcomes.

 

Conclusion

TAVR improves cognitive function, which is more obvious in patients presenting cognitive decline at baseline. There was also early decline of some specific functions in one quarter of patients that persisted at one year in 10% of these patients.

 

Original Title: Serial Changes in Cognitive Function Following Transcatheter Aortic Valve Replacement.

Reference: Vincent Auffret et al. J Am Coll Cardiol. 2016;68(20):2129-2141.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...